Lonza

Lonza is the leading CDMO for bioconjugates, supporting over 70 ADC programs since 2006 and producing more than 300 cGMP batches annually. Our integrated services span from late discovery to commercial manufacturing, leveraging deep expertise in small molecules, mammalian, microbial, and bioconjugate drug candidates. With cutting-edge technologies, including Synaffix’s ADC platform, and continued investment in large-scale manufacturing and drug product filling, we help biotechs and pharma companies bring innovative therapies to patients efficiently, safely, and at scale. Contact us and/or visit our website to find out more.